Author:
Juarso Edwin,Kiehl Malte,Buchholz Markus,Weißinger Florian
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. Robert Koch-Institut und die Gesellschaft der epidemiologischen Krebsregister in Deutschland e. V. (Hrsg) (2013) Krebs in Deutschland für 2013/2014. 11. Ausgabe Robert Koch-Institut (Hrsg.) und die Gesellschaft der epidemiologischen Krebsregister in Deutschland, Berlin. https://doi.org/10.17886/rkipubl-2017-007. ISBN 978-3-89606-288‑8
2. Gary LH, Poniewiersky MS, Crawford JDDC, Culakova E (2015) Cost of hospitalization in patients with cancer and febrile neutropenia and impact of comorbid conditions. Blood 126:2089
3. Cantwell L, Perkins J (2018) Infectious disease emergencies in oncology patients. Emerg Med Clin North Am. https://doi.org/10.1016/j.emc.2018.06.009
4. Heinz WJ, Buchheidt D, Christopeit M, von Lilienfeld-Toal M, Cornely OA, Einsele H, Karthaus M, Link H, Mahlberg R, Neumann S, Ostermann H, Penack O, Ruhnke M, Sandherr M, Schiel X, Vehreschild JJ, Weissinger F, Maschmeyer G (2017) Diagnosis and empiricial treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Disease Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Ann Hematol 96:1775–1792. https://doi.org/10.1007/s00277-017-3098-3
5. Pagano L, Caira M, Candoni A, Offidani M, Fianchi L, Martino B, Pastore D, Picardi M, Bonini A, Chierichini A, Fanci R, Caramatti C, Invernizzi R, Mattei D, Mitra ME, Melillo L, Aversa F, Van Lint MT, Falcucci P, Valentini CG, Girmenia C, Nosari A (2006) The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 Study. Haematologica 91:1068–1075